Profound Share Price

Profound Share Price

NASDAQ: PROF | Micro Cap | Healthcare
$6.65
-$0.27 (-3.97%) Last updated on 20 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Profound Stock Performance

Open
$6.68
Prev. Close
$6.92
Circuit Range
N/A
Day Range
$6.67 - $6.72
Year Range
$4.81 - $8.86
Volume
1,891
Average Traded
$6.70

Profound Share Price Today

As of 20 November 2026, Profound Medical Corp.'s share price is $6.65. The stock opened at $6.68, compared to its previous close of $6.92. During today's trading session, Profound Medical Corp.'s share price traded between $6.67 and $6.72, with an average price of $6.70. Over the past 52 weeks, the stock has recorded a high of $8.86 and a low of $4.81. In terms of performance, Profound Medical Corp.'s share price has declined by 1.92% over the last six months and is up 1.37% on a year-on-year basis.

Profound Share Price Chart

Line chart of the Profound price trend over the selected period. The price fell overall, ranging from 6.85 to 7.17, ending at 6.90.
$6.67$6.72
L
Show Current Price
H

Profound Stock Fundamentals & Key Indicators

Market Cap
$201.05M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.89
Revenue (TTM)
$16.10B
Return On Equity (TTM)
-76.42%
Profit Margin
-264.41%
Debt to Equity
0.11
Quarterly Earnings Growth YoY
5.62%

Profound Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$5.98$5.34$2.48$9.83
Net Profit-$8.18-$7.05-$9.54-$7.72
Net Profit Margin-136.79%-132.02%-384.68%-78.54%
Income ChangeN/A13.81%-35.32%19.08%

Profound Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$6.68$7.20$10.68$16.10
Net Profit-$28.67-$28.32-$27.82-$42.57
Net Profit Margin-429.19%-393.33%-260.49%-264.41%
Income ChangeN/A1.22%1.77%-53.02%

Profound Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets1.391.172.062.4
Current Assets76.0969.0741.962.02
Total Assets77.4870.2343.9664.42
Non Current Liabilities4.973.256.368.23
Current Liabilities6.086.576.374.19
Total Liabilities11.049.8112.7312.42
Shareholders' Equity66.4360.4231.2252.0

Profound Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-38.21-23.45-22.61-25.8
Investing-0.240.00.00.0
Financing41.1454.71.767.03

About Profound

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.

Profound Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$6.50
$6.72
+2.91%
Oct 2026
$5.87
$6.54
+11.52%
Sep 2026
$6.79
$5.86
-15.80%
Aug 2026
$7.37
$6.96
-5.37%
Jul 2026
$6.75
$7.36
+10.68%
Jun 2026
$6.85
$6.64
-1.99%
May 2026
$6.81
$6.78
-0.37%
Apr 2026
$6.62
$6.80
+5.10%
Mar 2026
$7.49
$6.47
-15.25%
Feb 2026
$7.52
$7.64
+1.73%
Jan 2026
$7.82
$7.51
-5.00%
Dec 2025
$6.37
$7.91
+20.50%

Profound Share Price FAQs